Moreover, as Rab11 has been implicated in both Huntington's and Alzheimer's diseases, such potential drug strategies may have a general clinical value for neurodegenerative diseases. The gene discussed is RAB11A; the disease is early-onset autosomal dominant Alzheimer disease.